It is overexpressed in ovarian cancer [20] and when compared with multiple biomarkers (including CA125), HE4 demonstrated the highest sensitivity for distinguishing ovarian cancer from benign disease (72.9% at 95% specificity) [15]. This evidence concerns the gene WFDC2 and ovarian cancer.